Pharmacokinetics of Aripiprazole: Clinical Summary

Formulations

Half-life

Elimination Mainly through hepatic metabolism involving two P450 enzymes:

CYP3A4: dose adjustment might be needed in the presence of inhibitors or inducers.
CYP2D6: dose adjustment might be needed in the presence of inhibitors.

Pharmacokinetics of aripiprazole: metabolism by cytochrome P450 3A4

Pharmacokinetics of aripiprazole: metabolism by cytochrome P450 2D6

Peak plasma concentrations occur within 3 to 5 hours.
Can be administered with or without food.
According to the manufacturer, a study found that plasma concentrations from the oral solution were higher than that from the tablet formulation.

The volume of distribution in studies after IV administration is of 404 L or 4.9L/Kg (extense extravascular distribution)
Aripiprazole and dehydro-aripiprazole are greater than 99% bound to serum proteins (primarily albumin)

Median times to the peak plasma concentration: 1 hours and 3 hours.
In one pharmacokinetic study [Boulton,2008], intramuscular aripiprazole demonstrated more rapid attainment of plasma aripiprazole concentrations than oral aripiprazole (78% and 5% of peak plasma concentration [Cmax] values at 0.5 hours postdose, respectively).

Schatzberg, AF, Nemeroff, C . The American Psychiatric Publishing Textbook of Psychopharmacology. 4th ed.American Psychiatric Publishing, 2009.
Otsuka America Pharmaceutical, Inc. Abilify (aripiprazole) prescribing information. Retrieved from http://www.abilify.com
Boulton DW, Kollia G, Mallikaarjun S, Komoroski B, Sharma A, Kovalick LJ, et al. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. Clinical pharmacokinetics. 2008;47(7):475-85